4//SEC Filing
Feder Julie B 4
Accession 0000899243-22-034838
CIK 0001501796other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 8:39 PM ET
Size
5.3 KB
Accession
0000899243-22-034838
Insider Transaction Report
Form 4
Feder Julie B
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-10-31$12.45/sh−2,015$25,090→ 24,235 total
Footnotes (2)
- [F1]The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.45 to $12.487, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001710237
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 8:39 PM ET
- Size
- 5.3 KB